Literature DB >> 454415

Augmentation by thymidine of the incorporation and distribution of 5-fluorouracil in ribosomal RNA.

C K Carrico, R I Glazer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 454415     DOI： 10.1016/0006-291x(79)92010-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  5 in total

1.  The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.

Authors:  R Kanamaru; H Kakuta; T Sato; C Ishioka; A Wakui
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate.

Authors:  S B Howell; S J Mansfield; R Taetle
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Uridine rescue from the lethal toxicity of 5-fluorouracil in mice.

Authors:  P Klubes; I Cerna; M A Meldon
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU). An experimental study in the pig.

Authors:  M Andersson; L Domellöf; S Häggmark; G Johansson; S Reiz; B Gustavsson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.

Authors:  M H Berne; B G Gustavsson; O Almersjö; P C Spears; R Frösing
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.